Outcomes of adults with relapsed or refractory Burkitt and high‐grade B‐cell leukemia/lymphoma

Saved in:
Bibliographic Details
Published in:American journal of hematology 2017-06, Vol.92 (6), p.E114-E117
Main Authors: Short, Nicholas J., Kantarjian, Hagop M., Ko, Heidi, Khoury, Joseph D., Ravandi, Farhad, Thomas, Deborah A., Garcia‐Manero, Guillermo, Khouri, Maria, Cortes, Jorge E., Wierda, William G., Verstovsek, Srdan, Estrov, Zeev, Ferrajoli, Alessandra, Thompson, Philip A., Pierce, Sherry, O'Brien, Susan M., Jabbour, Elias
Format: Article
Language:English
Subjects:
Adult
Antineoplastic Agents, Immunological - therapeutic use
Antineoplastic Combined Chemotherapy Protocols - administration & dosage
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Asparaginase - administration & dosage
Burkitt Lymphoma - drug therapy
Burkitt Lymphoma - epidemiology
Cyclophosphamide - administration & dosage
Dexamethasone - administration & dosage
Disease-Free Survival
Doxorubicin - administration & dosage
Drug Resistance, Neoplasm
Etoposide - administration & dosage
Follow-Up Studies
Hematology
Humans
Kaplan-Meier Estimate
Leukemia, B-Cell - drug therapy
Leukemia, B-Cell - epidemiology
Lymphocytes B
Lymphoma
Lymphoma, B-Cell - drug therapy
Lymphoma, B-Cell - epidemiology
Lymphoma, Non-Hodgkin - drug therapy
Lymphoma, Non-Hodgkin - epidemiology
Methotrexate - administration & dosage
Polyethylene Glycols - administration & dosage
Prednisone - administration & dosage
Recurrence
Remission Induction
Retrospective Studies
Rituximab - therapeutic use
Salvage Therapy
Treatment Outcome
Vincristine - administration & dosage
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0361-8609
1096-8652
DOI:10.1002/ajh.24720